Lakefront Biotherapeutics NV
LKFT- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001421876
No open-market purchases or sales by Lakefront Biotherapeutics NV insiders were filed in the last 90 days; 76 institutions reported holding it in 13F filings for Q2 2026, worth $960.3M in total; Greenlight Capital is the only superinvestor holding it.
Other share classesGLPGF
13F holders, Q2 2021
Institutional positions in Lakefront Biotherapeutics NV as of Jun 30, 2021. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 109
- −22 vs. Q1 2021
- Shares held
- 7.51M
- +950.0K (+14.5%) vs. Q1 2021
- Total value
- $517.2M
- +$11.9M (+2.4%) vs. Q1 2021
- New holders
- 13
- 38 more added
- Sold out
- 35
- 42 more reduced
2 institutions that held it in Q1 2021 haven't filed for Q2 2021 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q1 2021: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting LKFT on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 76 | $960.3M |
| Q1 2026 | 90 | $937.9M |
| Q4 2025 | 91 | $1.03B |
| Q3 2025 | 92 | $1.09B |
| Q2 2025 | 85 | $887.2M |
| Q1 2025 | 83 | $783.2M |
| Q4 2024 | 82 | $856.9M |
| Q3 2024 | 79 | $393.4M |
| Q2 2024 | 85 | $494.0M |
| Q1 2024 | 83 | $659.6M |
| Q4 2023 | 88 | $804.5M |
| Q3 2023 | 73 | $662.4M |
| Q2 2023 | 76 | $801.4M |
| Q1 2023 | 76 | $703.8M |
| Q4 2022 | 75 | $584.8M |
| Q3 2022 | 84 | $551.1M |
| Q2 2022 | 82 | $720.0M |
| Q1 2022 | 90 | $795.8M |
| Q4 2021 | 83 | $595.0M |
| Q3 2021 | 81 | $449.8M |
| Q2 2021 | 109 | $517.2M |
| Q1 2021 | 133 | $506.0M |
Institutions, Q2 2021
Shares, value and share of portfolio for each institution holding Lakefront Biotherapeutics NV; share changes are against Q1 2021.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| OrbiMed Advisors LLC | 230,905 | $15.9M | 0.16% | 00.0% | Unchanged |
| Parallax Volatility Advisers, L.P. | 233,917 | $16.1M | 0.20% | +72,332+44.8% | Added |
| BlackRock Inc. | 407,175 | $28.1M | 0.00% | +346,013+565.7% | Added |
| Citadel Advisors LLC | 453,179 | $31.2M | 0.03% | +161,512+55.4% | Added |
| FMR LLC | 604,499 | $41.6M | 0.00% | −240.0% | Reduced |
| Deerfield Management Company, L.P. (Series C) | 657,005 | $45.3M | 0.80% | +657,005 | New |
| Point72 Asset Management, L.P. | 712,156 | $49.1M | 0.24% | +246,678+53.0% | Added |
| Capital International Investors | 1,731,410 | $119.3M | 0.03% | −103,333−5.6% | Reduced |
| Sofos Investments, Inc. | 64 | – | – | −17−21.0% | Reduced |
| Federated Hermes, Inc. | 0 | $0 | 0.00% | −165,000−100.0% | Sold out |
| Susquehanna International Securities, Ltd. | 0 | $0 | 0.00% | −21,700−100.0% | Sold out |
| Capital Fund Management S.A. | 0 | $0 | 0.00% | −19,223−100.0% | Sold out |
| Acadian Asset Management LLC | 0 | $0 | 0.00% | −14,087−100.0% | Sold out |
| Stifel Financial Corp | 0 | $0 | 0.00% | −12,560−100.0% | Sold out |
| Baker Bros. Advisors LP | 0 | $0 | 0.00% | −11,180−100.0% | Sold out |
| Stonepine Capital Management, LLC | 0 | $0 | 0.00% | −10,000−100.0% | Sold out |
| Bank of New York Mellon Corp | 0 | $0 | 0.00% | −8,327−100.0% | Sold out |
| First Republic Investment Management, Inc. | 0 | $0 | 0.00% | −5,821−100.0% | Sold out |
| Raymond James & Associates | 0 | $0 | 0.00% | −5,701−100.0% | Sold out |
| United Capital Financial Advisers, LLC | 0 | $0 | 0.00% | −5,488−100.0% | Sold out |
| Crossmark Global Holdings, Inc. | 0 | $0 | 0.00% | −5,476−100.0% | Sold out |
| FDx Advisors, Inc. | 0 | $0 | 0.00% | −4,247−100.0% | Sold out |
| Avoro Capital Advisors LLC | 0 | $0 | 0.00% | −3,100−100.0% | Sold out |
| Lumina Fund Management LLC | 0 | $0 | 0.00% | −3,000−100.0% | Sold out |
| LVW Advisors, LLC | 0 | $0 | 0.00% | −2,938−100.0% | Sold out |
| Quantbot Technologies LP | 0 | $0 | 0.00% | −2,300−100.0% | Sold out |
| Geneos Wealth Management Inc. | 0 | $0 | 0.00% | −1,638−100.0% | Sold out |
| Shay Capital LLC | 0 | $0 | 0.00% | −610−100.0% | Sold out |
| RMR Wealth Builders | 0 | $0 | 0.00% | −434−100.0% | Sold out |
| Standard Family Office LLC | 0 | $0 | 0.00% | −429−100.0% | Sold out |
| Private Capital Group, LLC | 0 | $0 | 0.00% | −270−100.0% | Sold out |
| Lumature Wealth Partners, LLC | 0 | $0 | 0.00% | −269−100.0% | Sold out |
| Bank of Montreal | 0 | $0 | 0.00% | −174−100.0% | Sold out |
| Bessemer Group Inc | 0 | $0 | 0.00% | −163−100.0% | Sold out |
| Harbor Investment Advisory, LLC | 0 | $0 | 0.00% | −159−100.0% | Sold out |
| American Portfolios Advisors | 0 | $0 | 0.00% | −110−100.0% | Sold out |
| Sowell Financial Services LLC | 0 | $0 | 0.00% | −79−100.0% | Sold out |
| Fifth Third Bancorp | 0 | $0 | 0.00% | −51−100.0% | Sold out |
| International Assets Investment Management, LLC | 0 | $0 | 0.00% | −44−100.0% | Sold out |
| FourThought Financial, LLC | 0 | $0 | 0.00% | −52−100.0% | Sold out |
| Front Row Advisors LLC | 0 | $0 | 0.00% | −32−100.0% | Sold out |
| Eudaimonia Partners, LLC | 0 | $0 | 0.00% | −17−100.0% | Sold out |
| Raffa Wealth Management, LLC | 0 | $0 | 0.00% | −3−100.0% | Sold out |
| Fieldpoint Private Securities, LLC | 0 | $0 | 0.00% | −5−100.0% | Sold out |
| OneAscent Wealth Management LLC | – | – | – | – | Not filed |
| OneAscent Financial Services LLC | – | – | – | – | Not filed |